Carnitine Derivatives Beyond Fatigue: an Update

Overview

Journal Curr Opin Gastroenterol

Specialty Gastroenterology

Date 2023 Feb 23

PMID 36821461

Authors

Michele Malaguarnera

Vito Emanuele Catania

Mariano Malaguarnera

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Carnitine is an essential micronutrient that transfer long-chain fatty acids from the cytoplasm into the mitochondrial matrix for the β-oxidation. Carnitine is also needed for the mitochondrial efflux of acyl groups in the cases wherein substrate oxidation exceeds energy demands.

Recent Findings: Carnitine deficiency can affect the oxidation of free fatty acids in the mitochondria resulting in the aggregation of lipids in the cytoplasm instead of entering the citric acid cycle. The aggregation leads a lack of energy, acetyl coenzyme A accumulation in the mitochondria and cytotoxic production.

Summary: Carnitine and its derivatives show great clinical therapeutic effect without significant side effects.

References

Malaguarnera G, Catania V, Bonfiglio C, Bertino G, Vicari E, Malaguarnera M . Carnitine Serum Levels in Frail Older Subjects. Nutrients. 2020; 12(12). PMC: 7766818. DOI: 10.3390/nu12123887. View

Crentsil V . Mechanistic contribution of carnitine deficiency to geriatric frailty. Ageing Res Rev. 2010; 9(3):265-8. DOI: 10.1016/j.arr.2010.02.005. View

Malaguarnera M . Acetyl-L-carnitine in hepatic encephalopathy. Metab Brain Dis. 2013; 28(2):193-9. DOI: 10.1007/s11011-013-9376-4. View

Malaguarnera M . Carnitine derivatives: clinical usefulness. Curr Opin Gastroenterol. 2012; 28(2):166-76. DOI: 10.1097/MOG.0b013e3283505a3b. View

Olson K, Schell J, Rutter J . Pyruvate and Metabolic Flexibility: Illuminating a Path Toward Selective Cancer Therapies. Trends Biochem Sci. 2016; 41(3):219-230. PMC: 4783264. DOI: 10.1016/j.tibs.2016.01.002. View

Ribas G, Vargas C, Wajner M . L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders. Gene. 2013; 533(2):469-76. DOI: 10.1016/j.gene.2013.10.017. View

Hiraoka A, Kiguchi D, Ninomiya T, Hirooka M, Abe M, Matsuura B . Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?. Eur J Gastroenterol Hepatol. 2019; 31(7):878-884. DOI: 10.1097/MEG.0000000000001368. View

Obre E, Rossignol R . Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy. Int J Biochem Cell Biol. 2014; 59:167-81. DOI: 10.1016/j.biocel.2014.12.008. View

Chiechio S, Copani A, Nicoletti F, Gereau 4th R . L-acetylcarnitine: a proposed therapeutic agent for painful peripheral neuropathies. Curr Neuropharmacol. 2008; 4(3):233-7. PMC: 2430690. DOI: 10.2174/157015906778019509. View

10.

Iwasa M, Sugimoto R, Ishihara T, Sekoguchi-Fujikawa N, Yoshikawa K, Mifuji-Moroka R . Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma. J Nutr Sci Vitaminol (Tokyo). 2016; 61(6):433-40. DOI: 10.3177/jnsv.61.433. View

11.

Muoio D . Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock. Cell. 2014; 159(6):1253-62. PMC: 4765362. DOI: 10.1016/j.cell.2014.11.034. View

12.

Tokuchi Y, Suda G, Kimura M, Maehara O, Kitagataya T, Kubo A . Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals. Sci Rep. 2021; 11(1):16616. PMC: 8368156. DOI: 10.1038/s41598-021-96203-z. View

13.

Hiramatsu A, Aikata H, Uchikawa S, Ohya K, Kodama K, Nishida Y . Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis. Hepatol Commun. 2019; 3(3):348-355. PMC: 6396356. DOI: 10.1002/hep4.1309. View

14.

Xu Y, Jiang W, Chen G, Zhu W, Ding W, Ge Z . L-carnitine treatment of insulin resistance: A systematic review and meta-analysis. Adv Clin Exp Med. 2017; 26(2):333-338. DOI: 10.17219/acem/61609. View

15.

Smith R, Soeters M, Wust R, Houtkooper R . Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease. Endocr Rev. 2018; 39(4):489-517. PMC: 6093334. DOI: 10.1210/er.2017-00211. View

16.

Virmani M, Cirulli M . The Role of l-Carnitine in Mitochondria, Prevention of Metabolic Inflexibility and Disease Initiation. Int J Mol Sci. 2022; 23(5). PMC: 8910660. DOI: 10.3390/ijms23052717. View

17.

Maldonado C, Guevara N, Queijo C, Gonzalez R, Fagiolino P, Vazquez M . Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia. Biomed Res Int. 2016; 2016:2920108. PMC: 4779505. DOI: 10.1155/2016/2920108. View

18.

Abe K, Fujita M, Hayashi M, Takahashi A, Ohira H . The Efficacy of Levocarnitine Treatment in Relieving Fatigue in Patients with Cirrhosis but without Overt Hepatic Encephalopathy. Intern Med. 2021; 60(22):3533-3542. PMC: 8666222. DOI: 10.2169/internalmedicine.7175-21. View

19.

Armstrong C, McGregor N, Butt H, Gooley P . Metabolism in chronic fatigue syndrome. Adv Clin Chem. 2014; 66:121-72. DOI: 10.1016/b978-0-12-801401-1.00005-0. View

20.

Vasiljevski E, Burns J, Bray P, Donlevy G, Mudge A, Jones K . L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial. Am J Med Genet A. 2021; 185(10):2976-2985. PMC: 9290089. DOI: 10.1002/ajmg.a.62392. View